Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymidylate Synthase | 9 | 2018 | 42 | 2.160 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 659 | 0.760 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1070 | 0.540 |
Why?
|
| Uracil | 2 | 2008 | 18 | 0.380 |
Why?
|
| Primates | 1 | 2011 | 14 | 0.380 |
Why?
|
| Biological Evolution | 1 | 2011 | 86 | 0.360 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2006 | 77 | 0.330 |
Why?
|
| Protein Conformation | 5 | 2018 | 362 | 0.320 |
Why?
|
| Quinazolines | 4 | 2018 | 70 | 0.310 |
Why?
|
| Thiophenes | 4 | 2018 | 76 | 0.310 |
Why?
|
| DNA | 1 | 2008 | 597 | 0.260 |
Why?
|
| Mutation | 4 | 2018 | 1213 | 0.200 |
Why?
|
| Circular Dichroism | 2 | 2011 | 99 | 0.190 |
Why?
|
| Ligands | 4 | 2011 | 317 | 0.170 |
Why?
|
| Pregnadienes | 1 | 2018 | 2 | 0.160 |
Why?
|
| Catalytic Domain | 1 | 2018 | 99 | 0.150 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 78 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2018 | 94 | 0.140 |
Why?
|
| Neoplasms | 1 | 2008 | 1667 | 0.140 |
Why?
|
| Protein Binding | 3 | 2011 | 1027 | 0.130 |
Why?
|
| Escherichia coli | 1 | 2018 | 368 | 0.130 |
Why?
|
| DNA Damage | 2 | 2008 | 190 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1745 | 0.130 |
Why?
|
| DNA Repair | 2 | 2005 | 127 | 0.120 |
Why?
|
| Enzyme Stability | 3 | 2010 | 30 | 0.100 |
Why?
|
| Humans | 10 | 2018 | 68618 | 0.100 |
Why?
|
| Gorilla gorilla | 1 | 2011 | 1 | 0.100 |
Why?
|
| Lemur | 1 | 2011 | 1 | 0.100 |
Why?
|
| Pan troglodytes | 1 | 2011 | 6 | 0.100 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2011 | 9 | 0.090 |
Why?
|
| Casein Kinase II | 1 | 2011 | 11 | 0.090 |
Why?
|
| Macaca mulatta | 1 | 2011 | 77 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 77 | 0.090 |
Why?
|
| Animals | 7 | 2011 | 20881 | 0.090 |
Why?
|
| Diphosphonates | 1 | 2011 | 39 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 136 | 0.090 |
Why?
|
| Valine | 1 | 2010 | 43 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2010 | 42 | 0.090 |
Why?
|
| Phylogeny | 1 | 2011 | 197 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 137 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 420 | 0.090 |
Why?
|
| Folic Acid Deficiency | 1 | 2008 | 16 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1447 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2673 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2011 | 1200 | 0.080 |
Why?
|
| Floxuridine | 1 | 2006 | 20 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2010 | 546 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2006 | 26 | 0.070 |
Why?
|
| Preventive Medicine | 1 | 2006 | 48 | 0.070 |
Why?
|
| Fluorouracil | 1 | 2006 | 130 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2006 | 108 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2005 | 7 | 0.070 |
Why?
|
| Intestines | 1 | 2006 | 114 | 0.070 |
Why?
|
| Community Networks | 1 | 2006 | 96 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 219 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2006 | 236 | 0.060 |
Why?
|
| Protein Folding | 1 | 2004 | 82 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 282 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 631 | 0.050 |
Why?
|
| Mice | 4 | 2006 | 8474 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 581 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1664 | 0.040 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 190 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 1752 | 0.040 |
Why?
|
| Apoptosis | 1 | 2005 | 1641 | 0.040 |
Why?
|
| Kinetics | 2 | 2010 | 1047 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1536 | 0.030 |
Why?
|
| DNA Polymerase beta | 2 | 2005 | 9 | 0.030 |
Why?
|
| Transformation, Bacterial | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 262 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 204 | 0.020 |
Why?
|
| Crystallization | 1 | 2009 | 57 | 0.020 |
Why?
|
| Genes, APC | 1 | 2006 | 15 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 53 | 0.020 |
Why?
|
| Testis | 1 | 2006 | 37 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 43 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 166 | 0.020 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 4 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 99 | 0.020 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2005 | 17 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2006 | 228 | 0.020 |
Why?
|
| Models, Animal | 1 | 2006 | 252 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 176 | 0.020 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2004 | 7 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 235 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 955 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 312 | 0.010 |
Why?
|
| Incidence | 1 | 2006 | 1603 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 901 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2005 | 902 | 0.010 |
Why?
|
| Mass Screening | 1 | 2006 | 843 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 2791 | 0.010 |
Why?
|
| South Carolina | 1 | 2006 | 2752 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 4655 | 0.010 |
Why?
|
| Female | 2 | 2006 | 38074 | 0.010 |
Why?
|
| Male | 1 | 2006 | 37321 | 0.000 |
Why?
|